Xencor, Amgen In $1.7 Billion Deal
socalTECH
SEPTEMBER 16, 2015
Thousand Oaks-based Amgen , and Monrovia, California-based Xencor said this morning they are in a strategic collaboration worth as much as $1.7 billion based on certain regulatory and sales milestones, to combine Amgen's target discovery and protein therapeutics efforts with Xencor's XmAb b ispecific technology platform.
Let's personalize your content